Streetbeat News

Stock Prices

FANG

Diamondback Energy (NYSE:FANG) has seen a 6.3% decrease in short interest since its last report, with 5.84 million shares sold short, representing 3.72% of its float. The average time to cover these short positions is 3.81 days. A decrease in short interest can indicate a more bullish sentiment towards the stock. Compared to its peers, Diamondback Energy has a lower short interest as a percentage of float, with the peer group average at 5.98%.

Portfolio Pulse from Benzinga Insights

December 26, 2023 | 4:00 pm

PLD

Over the past 5 years, Prologis (NYSE:PLD) has delivered an average annual return of 17.78%, outperforming the market by 4.08% on an annualized basis. A $1000 investment in PLD 5 years ago would be worth $2,275.68 today. Prologis currently has a market cap of $122.98 billion.

Portfolio Pulse from Benzinga Insights

December 26, 2023 | 4:00 pm

HALO

Halozyme Therapeutics (NASDAQ:HALO) has received mixed analyst ratings over the past three months, with 3 bullish and 1 somewhat bullish ratings. The average 12-month price target is $57.5, down from $60.50, with a high estimate of $61.00 and a low of $50.00. Analysts from Morgan Stanley, Benchmark, and HC Wainwright & Co. have adjusted their ratings and price targets. Halozyme is a biotech company focusing on oncology therapies. It has shown a revenue growth of 3.38%, a high net margin of 37.88%, an ROE of 40.9%, and an ROA of 4.42%, but carries a higher debt-to-equity ratio of 6.01 compared to the industry average.

Portfolio Pulse from Benzinga Insights

December 26, 2023 | 4:00 pm

BA

Boeing shares experienced a spike in volume after being mentioned on CNBC. The mention on a major news outlet may influence investor perception and trading activity in the short term.

Portfolio Pulse from Happy Mohamed

December 26, 2023 | 3:51 pm

AAL

AFLYY

GOL

GOL Linhas Aéreas Inteligentes S.A. (NYSE:GOL) has been approved to access a credit insurance policy supported by SE-Camex and backed by the FGE, allowing up to $209 million in financing for engine maintenance in Brazil. The company reported a 16.4% revenue growth in Q3 FY23 and has partnerships with American Airlines Group Inc (NASDAQ: AAL) and Air France-KLM (OTC: AFLYY). GOL's shares dropped slightly by 0.25% to $3.72.

Portfolio Pulse from Shivani Kumaresan

December 26, 2023 | 3:49 pm

AAPL

The White House upheld a sales ban on certain Apple Inc (NASDAQ:AAPL) smartwatches due to a patent violation with Masimo Corp. Apple Watch Series 9 and Ultra 2 were removed from stores, while the Apple Watch SE remains on sale. Analysts estimate Apple's watch business generated $17 billion last year, with the ban potentially costing $300-$400 million in holiday sales. Apple shares were down 0.18% at $193.26 following the news.

Portfolio Pulse from Adam Eckert

December 26, 2023 | 3:47 pm

ADAUSD

AVAXUSD

BTCUSD

ETHUSD

SOLUSD

XRPUSD

Digital assets have seen a shift from outflows to inflows, with Bitcoin (BTC) experiencing $87.6 million in inflows, reversing from last week's outflows. Ethereum (ETH) also saw inflows of $7.9 million. Altcoins like Solana (SOL) and Cardano (ADA) had decreased inflows, while XRP saw no new inflows and Avalanche (AVAX) outflows widened. Year-to-date flows for digital assets have reached $1.971 billion, with total assets under management at $52.098 billion. Germany leads in weekly inflows, followed by Canada and the U.S. Bitcoin prices dropped slightly by 0.5%, while ETH increased by 0.7%. SOL surged by 55%, and ADA, XRP, and AVAX also saw price increases.

Portfolio Pulse from Khyathi Dalal

December 26, 2023 | 3:46 pm

AMGN

The FDA has issued a Complete Response Letter to Amgen Inc (NASDAQ:AMGN) for full approval of Lumakras, a drug for KRAS G12C-mutated non-small cell lung cancer (NSCLC). Doubts were raised by FDA advisers in October about the primary goal of the late-stage study. The FDA requires an additional study to be completed by February 2028 for full approval. Lumakras received accelerated approval in May 2021 and has been used by over 15,000 patients globally. Amgen's shares dropped slightly by 0.45% to $282.89.

Portfolio Pulse from Vandana Singh

December 26, 2023 | 3:45 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo provides daily trade strategies for SPY, QQQ, AAPL, MSFT, GOOGL, META, TSLA, and NVDA, based on a proprietary formula considering price, volume, and options flow. The memo outlines potential support and resistance levels for each asset, suggesting possible breakouts or reversals. Traders are advised to monitor these stocks closely and adjust strategies according to market conditions. The memo also highlights the importance of volume monitoring and staying adaptable to market shifts.

Portfolio Pulse from RIPS

December 26, 2023 | 3:45 pm

CVRX

CVRx, Inc. has received FDA approval for expanded labeling of its Barostim device, leading to a rise in its stock price.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 3:38 pm